Skip to main content

Table 6 Bleeding complications in patients with or without cancer (safety population)

From: Heparin based prophylaxis to prevent venous thromboembolic events and death in patients with cancer - a subgroup analysis of CERTIFY

All patients Pts with cancer at admission Pts without cancer at admission OR (95%CI) p-value*
  n/avail. % n/avail. %   
Bleeding complications       
   with major bleeding 2/274 0.73 15/2965 0.51 1.45 (0.33-6.36) 0.6254
   with minor bleeding 9/274 3.28 101/2965 3.41 0.96 (0.48-1.93) 0.9152
  1. Legend: Pts, patients; SD, UFH, unfractionated heparin; OR, odds ratio; CI, confidence interval, * two-sided p-value for null-hypothesis: difference = 0 or odds ratio = 1.